Cancer is nonpartisan. It touches everyone — cutting across religion, race, ethnicity, sexual orientation and socioeconomic ...

Zac Mirecki reflects on six years of survivorship, sharing how his AML journey taught him to priori-tize self-care, seek ...

Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, ...

Fear is a powerful enemy of the mind but there’s another word that has the same power. That word is a six letter one, cancer.

Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia ...

Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice and return to the ...

Tamron Little was diagnosed with peritoneal mesothelioma in 2007 as a 21-year-old new mother. Catch up on Tamron's blogs here ...

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

T cells are a natural part of the immune system designed to fight infections and cancer, but in conditions like blood cancer, ...

The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.

Waldenström macroglobulinemia is often slow growing, with a 78% five-year survival rate, but chronic conditions can affect ...

Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care ...